/PRNewswire/ Seed Health, a microbiome science company, and the Swiss Institute of Allergy and Asthma Research (SIAF) today announced the launch of a new.
/PRNewswire/ January 1 - September 30, 2022 The third quarter in figures Net sales amounted to TSEK 4,941 (2,982), +66%. The loss after tax amounted to TSEK.
STOCKHOLM, Sept. 1, 2022 /PRNewswire/ SciBase Holding AB ("SciBase") (STO:SCIB), a leading developer of augmented intelligence-based solutions for skin disorders announced today scientific
Nature article presents impact and importance of epithelial barrier damage on a range of common diseases
News provided by
Share this article
STOCKHOLM, April 15, 2021 /PRNewswire/
SciBase Holding AB ( SciBase ) [STO:SCIB], a leading developer of augmented intelligence-based solutions for skin disorders, announced today the publication of a groundbreaking article presenting the epithelial barrier hypothesis in Nature Reviews Immunology. The article was written by Professor Cezmi Akdis at the Swiss institute of Allergy and Asthma Research (SIAF). Prof. Akdis is the key research collaborator in SciBase s product development for skin barrier assessment. The article presents the background for the steep increase in allergic diseases over the last decades, and how this increase is connected to industrialization and modern lifestyle.
Nature article presents impact and importance of epithelial barrier damage on a range of common diseases prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.